Lithium treatment and risk for dementia in adults with bipolar disorder: Population-based cohort study

British Journal of Psychiatry

Volumn 207, Issue 1, 2015, Pages 46-51

  Gerhard, Tobias ^a,b   Devanand, D P ^c   Huang, Cecilia ^a   Crystal, Stephen ^a   Olfson, Mark ^c  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR DISORDER; COHORT ANALYSIS; CONTROLLED STUDY; DEMENTIA; DRUG USE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK REDUCTION; TREATMENT DURATION; UNITED STATES; AGED; MEDICAID; MEDICARE; MIDDLE AGED; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEMENTIA; FEMALE; HUMANS; LITHIUM; MALE; MEDICAID; MEDICARE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84937204809     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.bp.114.154047     Document Type: Article

References (33)

1. Coryell W. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice. Bipolar Disord 2009; 11 (suppl 2): 77-83.
2. Blanco C, Laje G, Olfson M, Marcus SC, Pincus HA. Trends in the treatment of bipolar disorder by outpatient psychiatrists. Am J Psychiatry 2002; 159: 1005-10.
3. Young AH, Hammond JM. Lithium in mood disorders: increasing evidence base, declining use? Br J Psychiatry 2007; 191: 474-6.
4. Forlenza OV, De-Paula VJ, Diniz BS. Neuroprotective effects of lithium: implications for the treatment of alzheimer's disease and related neurodegenerative disorders. ACS Chem Neurosci 2014; May 6 (Epub ahead of print).
5. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-9.
6. Phiel CJ, Wilson CA, Lee VM, Klein PS. GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides. Nature 2003; 423: 435-9.
7. Forlenza OV, de Paula VJ, Machado-Vieira R, Diniz BS, Gattaz WF. Does lithium prevent Alzheimer's disease? Drugs Aging 2012; 29: 335-42.
8. Dunn N, Holmes C, Mullee M. Does lithium therapy protect against the onset of dementia? Alzheimer Dis Assoc Disord 2005; 19: 20-2.
9. Nunes PV, Forlenza OV, Gattaz WF. Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry 2007; 190: 359-60.
10. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010; 12: 87-94.
11. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008; 65: 1331-5.
12. Hampel H, Ewers M, Burger K, Annas P, Mortberg A, Bogstedt A, et al. Lithium trial in Alzheimer's disease: a randomized, single-blind, placebocontrolled, multicenter 10-week study. J Clin Psychiatry 2009; 70: 922-31.
13. Macdonald A, Briggs K, Poppe M, Higgins A, Velayudhan L, Lovestone S. A feasibility and tolerability study of lithium in Alzheimer's disease. Int J Geriatr Psychiatry 2008; 23: 704-11.
14. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 2011; 198: 351-6.
15. Nunes MA, Viel TA, Buck HS. Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease. Curr Alzheimer Res 2013; 10: 104-7.
16. Sproule BA, Hardy BG, Shulman KI. Differential pharmacokinetics of lithium in elderly patients. Drugs Aging 2000; 16: 165-77.
17. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261-9.
18. Wu KY, Chang CM, Liang HY, Wu CS, Chia-Hsuan Wu E, Chen CH, et al. Increased risk of developing dementia in patients with bipolar disorder: a nested matched case-control study. Bipolar Disord 2013; 15: 787-94.
19. Kessing LV, Olsen EW, Mortensen PB, Andersen PK. Dementia in affective disorder: a case-register study. Acta Psychiatr Scand 1999; 100: 176-85.
20. World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-9). WHO, 1978.
21. Ernst CL, Goldberg JF. Antidepressant properties of anticonvulsant drugs for bipolar disorder. J Clin Psychopharmacol 2003; 23: 182-92.
22. Nemeroff CB. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry 2000; 61 (supp 130): 19-25.
23. Setoguchi S, Gerhard T. Comparator selection. In Developing a Protocol for Observational Comparative Effectiveness Research: A User's Guide (eds P Velentgas, NA Dreyer, P Nourjah, R Scott, R Smith and MM Torchia): 59-70. AHRQ Publication No. 12(13)-EHC099. Agency for Healthcare Research and Quality, 2013 (www.effectivehealthcare.ahrq.gov/Methods-OCER.cfm).
24. Hebert PL, McBean AM, O'Connor H, Frank B, Good C, Maciejewski ML. Time until incident dementia among Medicare beneficiaries using centrally acting or non-centrally acting ACE inhibitors. Pharmacoepidemiol Drug Saf 2013; 22: 641-8.
25. Gruber-Baldini AL, Stuart B, Zuckerman IH, Hsu VD, Boockvar KS, Zimmerman S, et al. Sensitivity of nursing home cost comparisons to method of dementia diagnosis ascertainment. Int J Alzheimer Dis 2009; 2009: 780720.
26. Crane PK, Walker R, Larson EB. Glucose levels and risk of dementia. NEMJ 2013; 369: 1863-4.
27. Sahathevan R, Brodtmann A, Donnan GA. Dementia, stroke, and vascular risk factors; a review. Int J Stroke 2012; 7: 61-73.
28. Skoog I. Risk factors for vascular dementia: a review. Dementia 1994; 5: 137-44.
29. Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med 2011; 26: 546-50.
30. Johnson MJ, Sheard L, Maraveyas A, Noble S, Prout H, Watt I, et al. Diagnosis and management of people with venous thromboembolism and advanced cancer: how do doctors decide? A qualitative study. BMC Med Inform Decis Mak 2012; 12: 75.
31. Fillit H, Geldmacher DS, Welter RT, Maslow K, Fraser M. Optimizing coding and reimbursement to improve management of Alzheimer's disease and related dementias. J Am Geriatr Soc 2002; 50: 1871-8.
32. Rothman KJ, Greenland S, Lash TL. Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins, 2008.
33. van der Flier WM, Scheltens P. Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry 2005; 76 (suppl 5): v2-7.